M
10b5-1 Plan
$ Value
$0
Shares
50,000
Price
$0
Filed
Dec 19
Insider
Name
Castagna Michael
Title
Chief Executive Officer
CIK
0001674282
Roles
Director
Officer
Transaction Details
Transaction Date
2025-12-17
Code
M
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
—
Footnotes
Transaction occurred pursuant to Rule 10b5-1 Plan established August 8, 2025. | The weighted average sales price of the reported transaction was $6.01 based on a range of prices between $6.00 and $6.04. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Filing Info
Castagna Michael's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-23 | MNKD | A | $0 |
| 2026-03-23 | MNKD | A | $0 |
| 2025-12-24 | MNKD | G | $0 |
| 2025-12-17 | MNKD | M | $299K |
| 2025-12-17 | MNKD | ▼ | $395K |
| 2025-12-17 | MNKD | M | $0 |
| 2025-12-17 | MNKD | M | $0 |
| 2025-12-16 | MNKD | M | $97K |
| 2025-12-16 | MNKD | ▼ | $128K |
| 2025-12-16 | MNKD | M | $0 |
Other Insiders at MNKD (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Thomson David
EVP Genl Counsel & Secretary
|
— | — | 2026-03-23 |
|
Tross Stuart A
Chief People & Workpl Officer
|
— | — | 2026-03-23 |
|
Castagna Michael
Chief Executive Officer
|
— | — | 2026-03-23 |
|
Prentiss Christopher B
Chief Financial Officer
|
— | — | 2026-03-23 |
|
Singh Sanjay R
EVP Technical Operations
|
— | — | 2026-03-23 |
|
Ahuja Ajay
Chief Medical Officer
|
— | — | 2026-03-23 |